A renowned pharmaceutical and healthcare company with a global presence was facing a rising challenge of counterfeit drugs being sold under its brand name. Concurrently, it aimed to advance its sustainability initiatives through the adoption of digital technologies. Ennoventure stepped in with its innovative, patented, and covert anti-counterfeit and brand protection solution. Let’s delve into the details of how this unfolded.
Counterfeit drugs are classified into drugs that contain no active pharmaceutical ingredients, incorrect amount of active pharmaceutical ingredients (or API), inaccurate or poor-quality API or adulterants. Moreover, they are produced in substandard conditions and deliberately packaged to look like genuine medication.
Most of the consumers today like to purchase everything online owing to convenience, privacy and cost savings and that includes medicines too. Little do they know that they might be exposed to counterfeit drugs which are in rampant and unregulated circulation on some websites which pose as genuine online pharmacies.
Counterfeit drugs are camouflaged by sophisticated counterfeiters to make them look exactly similar to the real drug, though their impact might range from no impact (due to the lack of harmful ingredients) to life-threatening impact (due to the presence of toxic
ingredients).
When consumers discover that they’ve purchased counterfeit drugs under a brand’s name, they naturally lose trust in that brand. Trust is a critical factor in the pharmaceutical industry, where consumers rely on the reputation of brands to ensure the efficacy and safety of their medications. A single incident of counterfeit drugs can erode years of trust-building efforts leading to severe reputational damage for the brand.
The brand wanted to leverage an anti-counterfeit and brand protection solution which could solve the issue of counterfeit drugs being sold under its name. In addition, as part of its sustainability campaign, the brand wanted to take steps towards digitization by replacing its printed material with digital leaflets and cut down its carbon footprint globally.
Ennoventure deployed its brand authentication solution which involved embedding unique invisible signatures on the product package which could be scanned easily using a smartphone to verify authenticity of the drugs in the market. With our covert anti-counterfeit solution, the brand personnel could track counterfeit medicines through real-time alerts triggered by each scan. The result was then displayed on a dashboard with the location and time stamp being shown.
After the genuine authentication scan, an e-leaflet in multiple languages was enabled for the users which provided them with detailed drug usage instructions, side-effects etc. The e-leaflets could be accessed in multiple global languages and zoomed in for easier readability. Moreover, the e-leaflets could be downloaded on a user’s smartphone for his future reference.
With Ennoventure’s groundbreaking covert anti-counterfeit solution, the brand was able to:
1. Get real-time scan updates along with location information
2. Do away with the printed material being published in multiple global languages and switch to hassle-free e-leaflets
3. Drive its sustainability efforts successfully with e-leaflets
4. Make the consumer, who was the most important stakeholder, as a part of the authentication journey- by allowing him to scan the medicine package with a smartphone to verify its authenticity
5. Save time and money by fast deployment without process change or CAPEX investments
Use Ennoventure’s technology to drive large-scale, high-velocity, data-driven anti-counterfeit and consumer awareness programs without any process change in the production or distribution.
1. High-velocity and scaled anti-counterfeit solutions
2. Invisible verification signature code – no change to artwork
3. No process change in the factory. Deploy the program very fast.
4. Real-time tracking dashboard – act on real-time data
5. Customisable app and webpage-based verification scans using a smartphone – empower stakeholders and consumers